These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1038 related articles for article (PubMed ID: 24091329)

  • 1. Inhibiting glycolytic metabolism enhances CD8+ T cell memory and antitumor function.
    Sukumar M; Liu J; Ji Y; Subramanian M; Crompton JG; Yu Z; Roychoudhuri R; Palmer DC; Muranski P; Karoly ED; Mohney RP; Klebanoff CA; Lal A; Finkel T; Restifo NP; Gattinoni L
    J Clin Invest; 2013 Oct; 123(10):4479-88. PubMed ID: 24091329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. mTORC1 and mTORC2 selectively regulate CD8⁺ T cell differentiation.
    Pollizzi KN; Patel CH; Sun IH; Oh MH; Waickman AT; Wen J; Delgoffe GM; Powell JD
    J Clin Invest; 2015 May; 125(5):2090-108. PubMed ID: 25893604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NF-κB-inducing kinase maintains T cell metabolic fitness in antitumor immunity.
    Gu M; Zhou X; Sohn JH; Zhu L; Jie Z; Yang JY; Zheng X; Xie X; Yang J; Shi Y; Brightbill HD; Kim JB; Wang J; Cheng X; Sun SC
    Nat Immunol; 2021 Feb; 22(2):193-204. PubMed ID: 33398181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced local and systemic anti-melanoma CD8+ T cell responses after memory T cell-based adoptive immunotherapy in mice.
    Contreras A; Sen S; Tatar AJ; Mahvi DA; Meyers JV; Srinand P; Suresh M; Cho CS
    Cancer Immunol Immunother; 2016 May; 65(5):601-11. PubMed ID: 27011014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutting Edge: Elevated Glycolytic Metabolism Limits the Formation of Memory CD8
    Tabilas C; Wang J; Liu X; Locasale JW; Smith NL; Rudd BD
    J Immunol; 2019 Nov; 203(10):2571-2576. PubMed ID: 31597706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aptamer-targeted inhibition of mTOR in T cells enhances antitumor immunity.
    Berezhnoy A; Castro I; Levay A; Malek TR; Gilboa E
    J Clin Invest; 2014 Jan; 124(1):188-97. PubMed ID: 24292708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial arginase-2 is a cell‑autonomous regulator of CD8+ T cell function and antitumor efficacy.
    Martí i Líndez AA; Dunand-Sauthier I; Conti M; Gobet F; Núñez N; Hannich JT; Riezman H; Geiger R; Piersigilli A; Hahn K; Lemeille S; Becher B; De Smedt T; Hugues S; Reith W
    JCI Insight; 2019 Nov; 4(24):. PubMed ID: 31751318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lactate dehydrogenase inhibition synergizes with IL-21 to promote CD8
    Hermans D; Gautam S; García-Cañaveras JC; Gromer D; Mitra S; Spolski R; Li P; Christensen S; Nguyen R; Lin JX; Oh J; Du N; Veenbergen S; Fioravanti J; Ebina-Shibuya R; Bleck C; Neckers LM; Rabinowitz JD; Gattinoni L; Leonard WJ
    Proc Natl Acad Sci U S A; 2020 Mar; 117(11):6047-6055. PubMed ID: 32123114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor cells and memory T cells converge at glycolysis: therapeutic implications.
    Karthikeyan S; Geschwind JF; Ganapathy-Kanniappan S
    Cancer Biol Ther; 2014 May; 15(5):483-5. PubMed ID: 24556820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microbiota-Derived Short-Chain Fatty Acids Promote the Memory Potential of Antigen-Activated CD8
    Bachem A; Makhlouf C; Binger KJ; de Souza DP; Tull D; Hochheiser K; Whitney PG; Fernandez-Ruiz D; Dähling S; Kastenmüller W; Jönsson J; Gressier E; Lew AM; Perdomo C; Kupz A; Figgett W; Mackay F; Oleshansky M; Russ BE; Parish IA; Kallies A; McConville MJ; Turner SJ; Gebhardt T; Bedoui S
    Immunity; 2019 Aug; 51(2):285-297.e5. PubMed ID: 31272808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Divergent roles for CD4+ T cells in the priming and effector/memory phases of adoptive immunotherapy.
    Hu HM; Winter H; Urba WJ; Fox BA
    J Immunol; 2000 Oct; 165(8):4246-53. PubMed ID: 11035058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The transcription factor Foxo1 controls central-memory CD8+ T cell responses to infection.
    Kim MV; Ouyang W; Liao W; Zhang MQ; Li MO
    Immunity; 2013 Aug; 39(2):286-97. PubMed ID: 23932570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dendritic cells charged with apoptotic tumor cells induce long-lived protective CD4+ and CD8+ T cell immunity against B16 melanoma.
    Goldszmid RS; Idoyaga J; Bravo AI; Steinman R; Mordoh J; Wainstok R
    J Immunol; 2003 Dec; 171(11):5940-7. PubMed ID: 14634105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced Therapeutic Efficacy and Memory of Tumor-Specific CD8 T Cells by
    Abu Eid R; Ahmad S; Lin Y; Webb M; Berrong Z; Shrimali R; Kumai T; Ananth S; Rodriguez PC; Celis E; Janik J; Mkrtichyan M; Khleif SN
    Cancer Res; 2017 Aug; 77(15):4135-4145. PubMed ID: 28615225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of tumor-infiltrating CD8+ T cell memory precursor effector cells and antimelanoma memory responses are the result of vaccination and TGF-β blockade during the perioperative period of tumor resection.
    Bellavance EC; Kohlhapp FJ; Zloza A; O'Sullivan JA; McCracken J; Jagoda MC; Lacek AT; Posner MC; Guevara-Patino JA
    J Immunol; 2011 Mar; 186(6):3309-16. PubMed ID: 21289306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adoptive transfer of ex vivo-activated memory T-cell subsets with cyclophosphamide provides effective tumor-specific chemoimmunotherapy of advanced metastatic murine melanoma and carcinoma.
    Gold JE; Zachary DT; Osband ME
    Int J Cancer; 1995 May; 61(4):580-6. PubMed ID: 7759164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type 1 and type 2 CD8+ effector T cell subpopulations promote long-term tumor immunity and protection to progressively growing tumor.
    Dobrzanski MJ; Reome JB; Dutton RW
    J Immunol; 2000 Jan; 164(2):916-25. PubMed ID: 10623840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FOXP3 expression diversifies the metabolic capacity and enhances the efficacy of CD8 T cells in adoptive immunotherapy of melanoma.
    Conde E; Casares N; Mancheño U; Elizalde E; Vercher E; Capozzi R; Santamaria E; Rodriguez-Madoz JR; Prosper F; Lasarte JJ; Lozano T; Hervas-Stubbs S
    Mol Ther; 2023 Jan; 31(1):48-65. PubMed ID: 36045586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic DC Activation Modulates the Tumor Microenvironment and Shapes the Long-Lived Tumor-Specific Memory Mediated by CD8+ T Cells.
    Shimizu K; Yamasaki S; Shinga J; Sato Y; Watanabe T; Ohara O; Kuzushima K; Yagita H; Komuro Y; Asakura M; Fujii S
    Cancer Res; 2016 Jul; 76(13):3756-66. PubMed ID: 27371739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants of successful CD8+ T-cell adoptive immunotherapy for large established tumors in mice.
    Klebanoff CA; Gattinoni L; Palmer DC; Muranski P; Ji Y; Hinrichs CS; Borman ZA; Kerkar SP; Scott CD; Finkelstein SE; Rosenberg SA; Restifo NP
    Clin Cancer Res; 2011 Aug; 17(16):5343-52. PubMed ID: 21737507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 52.